269 related articles for article (PubMed ID: 7791782)
1. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron.
Bergers G; Graninger P; Braselmann S; Wrighton C; Busslinger M
Mol Cell Biol; 1995 Jul; 15(7):3748-58. PubMed ID: 7791782
[TBL] [Abstract][Full Text] [Related]
2. Attenuated expression of the serum responsive T1 gene in ras transformed fibroblasts due to the inhibition of c-fos gene activity.
Kessler R; Zacharova-Albinger A; Laursen NB; Kalousek M; Klemenz R
Oncogene; 1999 Mar; 18(9):1733-44. PubMed ID: 10208434
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.
Babu RL; Naveen Kumar M; Patil RH; Devaraju KS; Ramesh GT; Sharma SC
Mol Cell Biochem; 2013 Aug; 380(1-2):143-51. PubMed ID: 23625206
[TBL] [Abstract][Full Text] [Related]
4. DEP-induced fra-1 expression correlates with a distinct activation of AP-1-dependent gene transcription in the lung.
Zhang Q; Kleeberger SR; Reddy SP
Am J Physiol Lung Cell Mol Physiol; 2004 Feb; 286(2):L427-36. PubMed ID: 14565943
[TBL] [Abstract][Full Text] [Related]
5. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently.
Young MR; Nair R; Bucheimer N; Tulsian P; Brown N; Chapp C; Hsu TC; Colburn NH
Mol Cell Biol; 2002 Jan; 22(2):587-98. PubMed ID: 11756554
[TBL] [Abstract][Full Text] [Related]
6. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
[TBL] [Abstract][Full Text] [Related]
7. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.
Cook SJ; Aziz N; McMahon M
Mol Cell Biol; 1999 Jan; 19(1):330-41. PubMed ID: 9858557
[TBL] [Abstract][Full Text] [Related]
8. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
[TBL] [Abstract][Full Text] [Related]
9. Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression.
Yoshioka K; Deng T; Cavigelli M; Karin M
Proc Natl Acad Sci U S A; 1995 May; 92(11):4972-6. PubMed ID: 7761434
[TBL] [Abstract][Full Text] [Related]
10. Difference in transcriptional regulatory function between c-Fos and Fra-2.
Suzuki T; Okuno H; Yoshida T; Endo T; Nishina H; Iba H
Nucleic Acids Res; 1991 Oct; 19(20):5537-42. PubMed ID: 1945831
[TBL] [Abstract][Full Text] [Related]
11. Fos family members: regulation, structure and role in oncogenic transformation.
Tulchinsky E
Histol Histopathol; 2000 Jul; 15(3):921-8. PubMed ID: 10963134
[TBL] [Abstract][Full Text] [Related]
12. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization.
Casalino L; De Cesare D; Verde P
Mol Cell Biol; 2003 Jun; 23(12):4401-15. PubMed ID: 12773579
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
15. SRY protein enhances transcription of Fos-related antigen 1 promoter constructs.
Cohen DR; Sinclair AH; McGovern JD
Proc Natl Acad Sci U S A; 1994 May; 91(10):4372-6. PubMed ID: 8183916
[TBL] [Abstract][Full Text] [Related]
16. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression.
Ramos-Nino ME; Timblin CR; Mossman BT
Cancer Res; 2002 Nov; 62(21):6065-9. PubMed ID: 12414630
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins.
Rutberg SE; Saez E; Glick A; Dlugosz AA; Spiegelman BM; Yuspa SH
Oncogene; 1996 Jul; 13(1):167-76. PubMed ID: 8700543
[TBL] [Abstract][Full Text] [Related]
18. p73 supports cellular growth through c-Jun-dependent AP-1 transactivation.
Vikhanskaya F; Toh WH; Dulloo I; Wu Q; Boominathan L; Ng HH; Vousden KH; Sabapathy K
Nat Cell Biol; 2007 Jun; 9(6):698-705. PubMed ID: 17496887
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone versus phorbol ester stimulation of activator protein-1 gene family members in rat osteosarcoma cells.
Koe RC; Clohisy JC; Tyson DR; Pulumati MR; Cook TF; Partridge NC
Calcif Tissue Int; 1997 Jul; 61(1):52-8. PubMed ID: 9192514
[TBL] [Abstract][Full Text] [Related]
20. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
